IATI Identifier:
CEPI 1.0 CEPI’s mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. The budget presented in this activity includes all investments + operating expenses and financial costs. • CFP1 on priority pathogens for EIDs: Launched January 2017 for the diseases Lassa, Nipah and MERS. The decision on priority diseases departed from pathogens identified by the WHO Blueprint for Action, followed by an in-depth assessment by the SAC. In recommending priority diseases to the CEPI Board, the SAC applied criteria related to 1) public health impact (potential of outbreak, transmissibility, burden of disease) and 2) feasibility (current scientific knowledge, pipeline candidates available). • CFP2 on platform technologies: Launched October 2017 to enable rapid vaccine development against both known and unknown pathogens that trigger infections with epidemic potential. A requirement is to produce sufficient vaccine doses to impact an emerging outbreak and that the platform demonstrates versatility one of the priority pathogens from the WHO Blueprint list. • CEPI’s third call for proposals (CfP3i) was for the development of human vaccines against Rift Valley fever and Chikungunya diseases. Rift Valley fever disease is included among the WHO R&D Blueprint list of priority pathogens in 2018, while Chikungunya is deemed to present a major public health risk where further R&D is needed. The call for proposals closed on March, 2019. • In addition to the vaccine development projects, CEPI has made several investments within the Enabling Science area, like biological standards and assays, data collection & scientific research, epidemiology and clinical development. • A global consortium is supporting the Government of the Democratic Republic of the Congo (DRC) to introduce a second investigational Ebola vaccine as part of ongoing efforts to contain the outbreak in eastern DRC. The large-scale clinical trial, sponsored by the London School of Hygiene & Tropical Medicine (LSHTM), is designed to help prevent the spread of the epidemic, the second worst in history, beyond the currently affected areas in eastern DRC, and if possible gather crucial information about the effectiveness of the vaccine to be better prepared to fight Ebola in the future. COVID-19 In 2020 CEPI launched a new call for proposals to develop vaccines against novel coronavirus, COVID-19. COVID-19 data is included in a separate IATI activity.
more_horizInfectious disease control
Name | Type | Role |
---|---|---|
Bill & Melinda Gates Foundation | Foundation | Funding |
Wellcome Trust | Foundation | Funding |
The Government of Norway | Government | Funding |
Government of Japan | Government | Funding |
The Government of Belgium | Government | Funding |
Government of Australia | Government | Funding |
The Government of the United Kingdom | Government | Funding |
International AIDS Vaccine Initiative | International NGO | Implementing |
IDT biologica | Private Sector | Implementing |
Inovio Pharmaceuticals | Private Sector | Implementing |
University of Oxford, The | Academic, Training and Research | Implementing |
Themis Bioscience | Private Sector | Implementing |
University of Tokyo | Academic, Training and Research | Implementing |
CureVac | Private Sector | Implementing |
Imperial College | Academic, Training and Research | Implementing |
University of Queensland | Academic, Training and Research | Implementing |
PATH | International NGO | Implementing |
Aurobindo | Private Sector | Implementing |
Public Health Vaccines | Private Sector | Implementing |
Emergent BioSolutions | Private Sector | Implementing |
Colorado State University | Academic, Training and Research | Implementing |
International Vaccines Institute | International NGO | Implementing |
Larissa | Other | Implementing |
Valneva | Private Sector | Implementing |
BNITM | Academic, Training and Research | Implementing |
Brighton Collaboration | National NGO | Implementing |
INRB | Local Government | Implementing |
LSHTM | Academic, Training and Research | Implementing |
MSF France | National NGO | Implementing |
University of Antwerpen | Academic, Training and Research | Implementing |
Epicentre | National NGO | Implementing |
Dalhousie Univesity | Academic, Training and Research | Implementing |
FIND | International NGO | Implementing |
Janssen | Private Sector | Implementing |
NIBSC | Other Public Sector | Implementing |
Tulane University | Academic, Training and Research | Implementing |
CDV Mali | Other Public Sector | Implementing |
University of North-Carolina | Academic, Training and Research | Implementing |
Nigeria NCDC | Other Public Sector | Implementing |
Benin FORS | Academic, Training and Research | Implementing |
Government of Ethiopia | Government | Funding |
European Commission | Other | Funding |
Vulcan | Private Sector | Funding |
Government of Canada | Government | Funding |
The Government of Germany | Government | Funding |
Government of Denmark | Government | Funding |
Government of Finland | Government | Funding |
Government of Indonesia | Government | Funding |
The Government of Netherlands | Government | Funding |
Government of Singapore | Government | Funding |
Government of South Korea | Government | Funding |
Government of Switzerland | Government | Funding |
The Government of Saudi Arabia | Government | Funding |
Taskforce for Global Health | National NGO | Implementing |
University of Queensland | Academic, Training and Research | Implementing |
Wageningen University & Research - Stichting Wageningen Research | Academic, Training and Research | Implementing |
University of Pittsburgh | Academic, Training and Research | Implementing |
Integrum | Private Sector | Implementing |
Robert Koch Institute | Academic, Training and Research | Implementing |
P-95 | Private Sector | Implementing |
United States Agency for International Development | Other Public Sector | Funding |
MERCK | Private Sector | Implementing |
Technical University of Mombasa | Academic, Training and Research | Implementing |
Medicines and Healthcare products Regulatory Agency (MHRA) | Other Public Sector | Implementing |
Universiti Malaya | Academic, Training and Research | Implementing |
Université Gamal Abdel Nasser de Conakry | Academic, Training and Research | Implementing |
Connected DMV | National NGO | Implementing |
Zalgen Labs | Private Sector | Implementing |
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) | Academic, Training and Research | Implementing |
Transaction Value |
Provider
Receiver |
Type | Date |
---|---|---|---|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|
|
Not Available | Provider N/A Receiver N/A |
date_range
|